Region
Featured experience
Atairos investment in the parent company of the Aston Villa Football Club
We are advising Atairos on the minority investment
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
$100 million investment by consortium in Airbus subsidiary AALTO
We are advising Airbus on the transaction
Svitzer Group demerger and Copenhagen listing
We advised A.P. Moller – Maersk and Svitzer Group on the demerger and commencement of trading in shares of Svitzer Group
BBVA $1 billion preferred securities offering
We advised BBVA on its offering of contingent convertible perpetual preferred securities
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
CRH $3 billion guaranteed notes offering
The investment-grade notes are due 2030, 2035 and 2055
Royalty Pharma $1.1 billion acquisition of its external manager and $3 billion share repurchase
We are advising Royalty Pharma on the transaction
Teoxane proposal to acquire Revance Therapeutics
We are advising Teoxane on the proposed acquisition
Paychex $4.1 billion acquisition of Paycor HCM
We are advising Paychex on the transaction
Banco Santander México $700 million senior notes offering
We advised Banco Santander México on the investment-grade offering
Nykredit cash tender offer for Spar Nord Bank
We are advising Nykredit on the tender offer
Amer Sports $1.05 billion follow-on offering
We advised Amer Sports on its SEC-registered offering
Aker BP $1.5 billion notes offering
The notes are due 2034 and 2054